BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4867418)

  • 1. Chemotherapy in management of bronchogenic carcinoma.
    Samuels ML; Leary WV; Howe CD
    Tex Med; 1967 Dec; 63(12):86-92. PubMed ID: 4867418
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
    Karrer K; Pridun N; Zwintz E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of radiologic and cytostatic combination therapy in malignant diseases].
    Hammer B
    Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
    Dundalek E
    Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
    Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
    Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytostatic therapy of tumors of the lung].
    De Marco F; Saviano G; Tenore G
    Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
    [No Abstract]   [Full Text] [Related]  

  • 7. Continued studies of combined chemotherapy and irradiation in inoperable bronchogenic carcinoma.
    Gollin FF; Ansfield FJ; Vermund H
    Cancer Chemother Rep; 1967 Jun; 51(3):189-92. PubMed ID: 6043739
    [No Abstract]   [Full Text] [Related]  

  • 8. Hodgkin's disease and some solid tumours.
    Jelliffe AM
    Proc R Soc Med; 1966 Dec; 59(12):1261-8. PubMed ID: 5955849
    [No Abstract]   [Full Text] [Related]  

  • 9. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
    Karrer K; Pridun N; Denck H
    Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer chemotherapy as a supplement to operation in bronchogenic carcinoma].
    Castberg T; Kruse-Blinkenberg HO
    Ugeskr Laeger; 1976 Jun; 138(24):1449-55. PubMed ID: 1273973
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Internal cancer therapy: cooperative clinical studies. Principles, organization and first results of the Swiss chemotherapy group].
    Praxis; 1967 Dec; 56(50):1691-5. PubMed ID: 5632569
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
    Vogl SE; Wollner D; Kaplan BH; Berenzweig M
    Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of polychemotherapy for bronchogenic carcinoma other than undifferentiated small cell carcinoma].
    Laberge F; Desmeules M; Bergeron D; La Forge J; Cormier Y
    Union Med Can; 1984 Mar; 113(3):222-4. PubMed ID: 6730096
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy as an adjunct to surgery in the treatment of pulmonary malignant disease.
    Mountain CF
    Acta Chir Belg; 1971 Apr; 70(4):351-64. PubMed ID: 5143081
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.
    Hansen HH; Muggia FM; Andrews R; Selawry OS
    Cancer; 1972 Aug; 30(2):315-24. PubMed ID: 4559404
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent therapeutic developments in lung cancer.
    Hansen HH; Selawry OS
    Med Ann Dist Columbia; 1971 Sep; 40(9):580-2. PubMed ID: 4939062
    [No Abstract]   [Full Text] [Related]  

  • 18. Status report of adjuvant cancer chemotherapy trials in the treatment of bronchial carcinoma.
    Shields TW
    Cancer Chemother Rep 3; 1973 Mar; 4(2):119-24. PubMed ID: 4729315
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
    Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
    Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
    Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.